Dr. Zhifeng Chen is a globally recognized expert in biomedical imaging, with a specialized focus on cutting-edge MRI acquisition strategies and advanced image reconstruction methodologies. Bridging the gap between academic research and industrial innovation, he currently holds the position of Principal Scientist and Clinical Research Collaboration Specialist at the Institute of Research and Clinical Innovations, Neusoft Medical Systems. Previously, he has served in prestigious research roles at Monash Biomedical Imaging, the University of Southern California, Harvard Medical School, and Massachusetts General Hospital.

Dr. Chen earned his Ph.D. in Biomedical Engineering from Zhejiang University. Over the past decade, his research has driven transformative progress in rapid neuroimaging, quantitative MRI, non-Cartesian acquisition, motion-robust dynamic contrast-enhanced MRI (DCE-MRI), precision motion correction, and deep learning-based medical imaging. He has authored over 80 peer-reviewed scientific publications, underscoring the depth, consistency, and international impact of his scholarly contributions.

His leadership spans numerous high-impact initiatives involving physics-informed deep learning, compressed sensing, low-rank subspace modeling, contrastive learning, and diffusion-based imaging frameworks. Beyond research, Dr. Chen plays an active role in the global scientific community as a reviewer for top-tier journals, a grant proposal evaluator, and a member of editorial boards, thereby shaping the direction and quality of medical imaging science worldwide.

Research Interest(s): MRI, Medical Physics, Inverse Problem, Signal Processing, Deep Learning

URL of your official website: https://www.linkedin.com/in/zhifeng-chen-0bb578bb/?locale=en_US

Research Interest: Dental Science,Bone Biology,Dental Implant

Research Interest: Biomedical research: Hartel, P. Principal Investigator. “Collection, Qualification, and Characterization of Biological Specimens for Research,” Analytic Biological Services and Davis Medical Center Clinical Trials: Fleming D, Hartel P. Multicentre, randomised, double-blind, Phase III trial to investigate the efficacy and safety of oral nintedanib plus docetaxel therapy compared to placebo plus docetaxel therapy in patients with stage IIIB/IV or recurrent, adenocarcinoma subtype non-small cell lung cancer after failure of first line chemotherapy, Boehringer Ingelheim, Protocol number 1199.128

Research Interest: Magnetic Resonance Imaging/Magnetic Resonance Spectroscopy/Diffusion Tensor Imaging Osteoporosis

Research Interest: His current research and clinical interests focus ontendinopathymanagement, electrotherapy, rehabilitation of musculoskeletal injuries of upper and lower extremities, epidemiology of sports and musculoskeletal injuries, validity and reliability of questionnaires in Greek and systematic reviews in the area of musculoskeletal injuries assessment, prevention, and rehabilitation.

Research Interest: My research interest is "autonomic dysfunction in vitamin B12 deficiency". My suugestion would be to be very selective in accepting images. "Clinical Image" section of NEJM is a good example to follow.

Research Interest: He is a Pediatric Nephrologist and a leading scientist in clinical studies in China especially for IgA nephropathy and nephritic syndrome in children. He also conducted basic research in regard to the investigation of the role of immunological aspects in kidney diseases including nephritic syndrome and diabetic nephropathy.

Research Interest: Fetal-neonatal nutrition and prevention of chronic diseases in adults such as obesity, diabetes and metabolic syndrome

Research Interest: Another field of interest are the neurological manifestations linked to HTLV-1 and their pathogenesis. Dr Louboutin is currently in Jamaica trying to get a better understanding of the physiopathology of tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM). The current collaboration with the Gene Therapy Program of the University of Pennsylvania is focused on gene therapy approach in different neurodegenerative disorders, (more particularly in lysosomal diseases, i.e., mucopolysaccharidosis, MPS).  Finally, Dr Louboutin is involved in cell therapy using stem cells in different tissues (i.e., bone marrow stem cells, skeletal muscle, Central Nervous System). This approach emphasizes the interaction with regenerative medicine in a translational context. Intramarrow gene delivery of SV40-derived vectors downregulating CCR5 resulted in the reduction of excitotoxin-induced seizures and their harmful consequences. These results emphasize the role of CCR5 in the immune-mediated process underlying some forms of epilepsy. He is the author of more than 80 papers in peer-reviewed journals and more than 10 book chapters

Research Interest: Transplantation, transplant immunology, artificial organs.

Research Interest: My area of interest is rheumatology and orthopedics, specifically osteoarthritis, falls, fractures.

Research Interest: Minimally invasive oral surgery, Implant dentistry, Bone RegenerationEndoscopes

Research Interest: His current interest is in clinical research and ophthalmology

Research Interest:  Currently Dr. Leiser is the head of the Laboratory for Oral Cancer Research and is supervising M.Sc. students in basic science research. Dr. Leiser specializes in surgical oncology and surgical dental rehabilitation in the maxillofacial region. The author of several scientific and clinical manuscripts in international peer-reviewed journals, he has actively participated as a lecturer in several international and national conferences in the basic sciences as well as at professional maxillofacial surgery and oncology conferences.